EBS fundamentals
An in-depth look to Emergent BioSolutions Inc. operating, investing, and financing activities
EBS free cash flow for Q3 24 is 147.9 M USD. For 2023, EBS free cash flow was -257.9 M USD and operating cash flow was -206.3 M USD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM